Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS) and BioNTech SE (BNTX)
at www.tipranks.com (Thu, 20-Aug 4:30 AM)
Xeris Biopharma Tightens 2026 Revenue Guidance as Recorlev Delivers 81% Growth and Key Patents Extend IP Horizon
Market Chameleon (Thu, 6-Aug 8:22 AM)
Xeris Biopharma Slashes Debt by $23 Million Through Private Exchange—Interest Savings Expected to Top $2 Million Annually
Market Chameleon (Fri, 12-Jun 10:30 AM)
